Sponsored By

Deal Could Enhance Cancer Diagnostics

Fujirebio Diagnostics, Inc. (Exton, PA), a leader in cancer diagnostics, announced it has bought rival CanAg Diagnostics AB (Gothenburg, Sweden). Both companies are known for their serum tumor markers. Combining the R&D efforts of both firms could enhance the development of new cancer assays, which are always needed.